Research and Markets: Global Market for Women’s Health Lab Testing and Mammography Instrumentation Examined
Research and Markets ( http://www.researchandmarkets.com/reports/c10832 ) has announced the addition of Women’s Health: Diagnostic Tests to their offering.
The report “Women’s Health: Diagnostic Tests”, covers women’s health oriented diagnostic test procedures and their markets. The discussion includes in vitro laboratory testing, as well as those segments that are highly active in terms of innovation and growth like imaging. Specifically, the global mammography markets are examined in terms of the markets for film based and digital mammography platforms, as well as accessory equipment, much of which is used to detect, capture, analyze, and send digital X-ray images.
Laboratory testing in the areas of pregnancy, fertility, infectious disease, cancer testing and prenatal testing and prenatal genetic testing are evaluated in terms of market size, growth rates, new testing procedures, and key players.
The emphasis in this report is on those companies and products that are actively developing and marketing women’s health oriented diagnostic tests and mammography products for the clinical setting.
This report makes an in-depth examination of the women’s health lab testing and mammography instrumentation market segments in the U.S., and around the world. Regional markets, sizes and growth rates are examined including the U.S., Europe, Japan and Asia, and the Rest of the World. Country market reports on women’s health diagnostic testing are covered for the U.S. the UK, France, Germany, Italy, Spain, China and Japan.
Particular attention is paid to those areas of the women’s health diagnostic testing sector that are showing the greatest growth or the most innovation.
The report surveys some of the key companies marketing, manufacturing or developing products for the women’s health diagnostic testing market in the world. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.
In a special section on business developments, the report discusses specific high profile issues in diagnostic testing such as sector consolidation, acquisition, license agreements, internal developments, and partnerships. Government regulation of diagnostic products in the U.S., Europe and the UK are explored.
This report will provide an In-depth analysis of the major sectors of the women’s health diagnostic testing sector, its size, growth rates and major drivers as well as a presentation of some of the emerging technology platforms, elucidating the potential areas that could gain traction in this market.
Companies Profiled Include:
— Abbott Diagnostics
— Adeza Biomedical Corporation
— Agfa-Gevaert Corp.
— Bayer Diagnostics
— Bioamerica, Inc.
— CADx Medical Systems
— CMT Medical Systems
— Cytyc
— Dalsa
— DBA Systems
— DiaDexus
— Diagnostic Imaging Systems
— Digene
— Fischer Imaging
— Fuji Medical Systems
— General Electric Medical Systems
— Genzyme Diagnostics
— Hologic, Inc.
— Home Access Health Corp
— ICAD
— Imaging Diagnostic Systems
— Instrumentarium Imaging Inc
— Inverness
— Jiangnan Biotech
— Kodak Health Imaging Division
— Lifescan Corporation
— Matritech
— Medisense
— Orasure
— Pharmatech Corporation
— Quidel
— R2 Technology, Inc
— Rad-icon Imaging Corp.
— Roche Diagnostics
— Scanis
— Selfcare
— Siemens Medical Solutions
— Smartlight
— Spectra Corp
— TriPath Imaging
— Vidar Systems Corporation
— Wampole
— Women’s Health Testing Technologies
For more information visit http://www.researchandmarkets.com/reports/c10832
